Certolizumab Pegol Efficacy in Patients With <scp>Non‐Radiographic</scp> Axial Spondyloarthritis Stratified by Baseline <scp>MRI</scp> and <scp>C‐Reactive</scp> Protein Status: An Analysis From the <scp>C‐axSpAnd</scp> Study

Philip C. Robinson, Walter P. Maksymowych, Lianne S. Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha de Peyrecave, Atul Deodhar

Open source

DOI
10.1002/acr2.11469
Published
2022-06-22
Container
ACR Open Rheumatology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acr2.11469,
  title = {Certolizumab Pegol Efficacy in Patients With <scp>Non‐Radiographic</scp> Axial Spondyloarthritis Stratified by Baseline <scp>MRI</scp> and <scp>C‐Reactive</scp> Protein Status: An Analysis From the <scp>C‐axSpAnd</scp> Study},
  author = {Philip C. Robinson and Walter P. Maksymowych and Lianne S. Gensler and Stephen Hall and Martin Rudwaleit and Bengt Hoepken and Lars Bauer and Thomas Kumke and Mindy Kim and Natasha de Peyrecave and Atul Deodhar},
  year = {2022},
  journal = {ACR Open Rheumatology},
  doi = {10.1002/acr2.11469},
  url = {https://doi.org/10.1002/acr2.11469}
}

RIS

TY  - JOUR
TI  - Certolizumab Pegol Efficacy in Patients With <scp>Non‐Radiographic</scp> Axial Spondyloarthritis Stratified by Baseline <scp>MRI</scp> and <scp>C‐Reactive</scp> Protein Status: An Analysis From the <scp>C‐axSpAnd</scp> Study
AU  - Philip C. Robinson
AU  - Walter P. Maksymowych
AU  - Lianne S. Gensler
AU  - Stephen Hall
AU  - Martin Rudwaleit
AU  - Bengt Hoepken
AU  - Lars Bauer
AU  - Thomas Kumke
AU  - Mindy Kim
AU  - Natasha de Peyrecave
AU  - Atul Deodhar
PY  - 2022
JO  - ACR Open Rheumatology
DO  - 10.1002/acr2.11469
UR  - https://doi.org/10.1002/acr2.11469
ER  - 

APA

Robinson, P. C., Maksymowych, W. P., Gensler, L. S., Hall, S., Rudwaleit, M., Hoepken, B., Bauer, L., Kumke, T., Kim, M., Peyrecave, N. D., & Deodhar, A. (2022). Certolizumab Pegol Efficacy in Patients With <scp>Non‐Radiographic</scp> Axial Spondyloarthritis Stratified by Baseline <scp>MRI</scp> and <scp>C‐Reactive</scp> Protein Status: An Analysis From the <scp>C‐axSpAnd</scp> Study. ACR Open Rheumatology. https://doi.org/10.1002/acr2.11469

Source records